These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9623336)

  • 41. A current review of medical therapy for benign prostatic hyperplasia.
    Brown GA; Sussman DO
    J Am Osteopath Assoc; 2004 Feb; 104(2 Suppl 2):S11-6. PubMed ID: 15038398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Filling and voiding symptoms in the American Urological Association symptom index: the value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia.
    Barry MJ; Williford WO; Fowler FJ; Jones KM; Lepor H
    J Urol; 2000 Nov; 164(5):1559-64. PubMed ID: 11025704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "Alphabet soup" and the prostate: LUTS, BPH, BPE, and BOO.
    Silverman WM
    J Am Osteopath Assoc; 2004 Feb; 104(2 Suppl 2):S1-4. PubMed ID: 15038396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A young man with generalized oedema, vomiting and easy fatiguability.
    Iyer VK;
    Natl Med J India; 2004; 17(3):152-9. PubMed ID: 15253403
    [No Abstract]   [Full Text] [Related]  

  • 45. Patients with alcoholic cirrhosis and cholelithiasis.
    Sataline LR
    Ann Surg; 1987 Nov; 206(5):683. PubMed ID: 3675030
    [No Abstract]   [Full Text] [Related]  

  • 46. [Safety ov benign prostatic hyperplasia treatment with alpha-adrenoblocker dalphas].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2000; (2):3-5. PubMed ID: 11186726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kobashigawa K; Kinjo F; Saito A
    Hepatogastroenterology; 2003; 50(54):2005-8. PubMed ID: 14696453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Upper abdominal complaints of unknown origin].
    Dörfler S
    MMW Munch Med Wochenschr; 1979 Feb; 121(8):36. PubMed ID: 106253
    [No Abstract]   [Full Text] [Related]  

  • 49. [Benign prostatic hyperplasia; recommendations for transmural care. Working Group, Dutch College of General Practitioners and Netherlands College of Urologists].
    Klomp ML; Rosmalen CF; Romeijnders AC; Oosterhof GO; Schlatmann TJ
    Ned Tijdschr Geneeskd; 1998 Nov; 142(47):2563-8. PubMed ID: 10028352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Alcoholic cirrhosis. Pathologic anatomy, diagnosis, complications and their physiopathology, treatment].
    Doffoël M
    Rev Prat; 1999 Feb; 49(3):320-6. PubMed ID: 10189803
    [No Abstract]   [Full Text] [Related]  

  • 51. [Non-alcoholic steato-hepatitis].
    Linhart HG
    Praxis (Bern 1994); 2000 May; 89(22):963-6. PubMed ID: 10893995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benign prostatic hyperplasia, sexual function, and overall evaluation of the male patient.
    Hellstrom WJ
    J Am Osteopath Assoc; 2004 Feb; 104(2 Suppl 2):S5-10. PubMed ID: 15038397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prostatilen effects on voiding disorders in patients with benign prostatic hyperplasia].
    Al'-Shukri SKh; Gorbachev AG; Borovets SIu; Belousov VIa; Kuz'min IV
    Urologiia; 2005; (5):25-6. PubMed ID: 16281835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Patients' complaints in chronic pyelonephritis].
    Lindqvist B
    Nord Med; 1965 Dec; 74(48):1223-5. PubMed ID: 5856944
    [No Abstract]   [Full Text] [Related]  

  • 55. [Predictive risk factors for progression to cirrhosis in early stage alcoholic liver disease].
    Giraud V; Naveau S; Balian A; Belda E; Capron F; Lemaigre G; Chaput JC
    Gastroenterol Clin Biol; 1998 Dec; 22(12):997-1002. PubMed ID: 10051977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Alcoholic fatty liver].
    Vidos I; Katona A; Schaff Z; Lapis K
    Orv Hetil; 1980 May; 121(21):1239-42. PubMed ID: 7422306
    [No Abstract]   [Full Text] [Related]  

  • 57. [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].
    Maksimov VA; Kamalov AA; Karpov VK; Riaboĭ AV; Prokhorov AV
    Urologiia; 2001; (2):37-40. PubMed ID: 11490716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nighttime urination.
    Harv Mens Health Watch; 2002 Jul; 6(12):6-8. PubMed ID: 12138029
    [No Abstract]   [Full Text] [Related]  

  • 59. Minimally invasive therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Elhilali MM
    J Urol; 2007 Mar; 177(3):820-1. PubMed ID: 17296350
    [No Abstract]   [Full Text] [Related]  

  • 60. FAQs: lower urinary tract symptoms in men.
    Belal M; Abrams P
    Practitioner; 2004 Sep; 248(1662):652, 654, 656 passim. PubMed ID: 15376550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.